Please login to the form below

Not currently logged in

Sanifit appoints Alexander Gold chief medical officer

He also serve as president of the Spanish biopharma's US subsidiary

Sanifit Alexander GoldSpanish biopharmaceutical company Laboratoris Sanifit has appointed Alexander Gold as chief medical officer and president of its US subsidiary.

He joins the Palma-headquartered company from Portola Pharmaceuticals, where he served as a senior vice president and head of clinical development.

Sanifit’s CEO Joan Perelló said, “We are very happy to have Dr Gold join our leadership team. Alex arrives here with first class operational and clinical development expertise in novel drug therapies, targeting cardiovascular and metabolic disease and kidney disease amongst others.

“In addition, his work in regulatory and medical affairs will be invaluable as we continue to take our novel clinical programmes through to approval.”

A cardiologist with over 16 years experience of drug development, Dr Gold is also an adjunct professor at Stanford University School of Medicine and has held various pharma leadership.

Prior to his time at Portola, Dr Gold was head of clinical development at Reata Pharmaceuticals and before that spent 11 years at AstraZeneca.

Sanifit, which focused on treatments for calcification disorders, was founded in 2007 as a spin-off of the University of the Balearic Islands and opened its first US office in San Diego in 2016.

18th December 2017

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...
figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...